What Psychedelics Are Actually Teaching Us About Mental Health

For decades, psychedelic research was effectively dead. The political crackdowns of the 1970s classified psilocybin, LSD, and similar compounds as Schedule I substances, shutting down a promising line of inquiry that had begun in the 1950s. But science has a way of circling back to things that work, and the last few years have produced some of the most compelling clinical data in psychiatry.

Two recent studies illustrate why this research matters, not as a fringe interest, but as a serious avenue for treating conditions that current medications often fail to address.

Psilocybin vs. Nicotine Patch: The Numbers

In 2026, Johnson and colleagues published the results of a pilot randomized clinical trial comparing psilocybin to nicotine patch for smoking cessation. Both groups received the same 13-week cognitive behavioral therapy program. The only difference was the pharmacological intervention: one group received a single high dose of psilocybin [30 mg/70 kg (that's roughly 0.028g of mushrooms per pound of body weight, or 4.3 grams of mushrooms for someone who weighed 154lbs)], while the other received a standard course of FDA-approved nicotine patch.

The results were dramatic. At six months after the target quit date, 40.5% of participants in the psilocybin group had achieved biochemically verified prolonged abstinence, compared to just 10% in the nicotine patch group. That translates to more than six times greater odds of sustained quitting with psilocybin. For seven-day point prevalence abstinence, the numbers were 52.4% versus 25%.

Tobacco kills approximately 8 million people worldwide each year. Most available treatments fail within six months. These results demand attention.

This was a pilot trial with 82 participants, so larger studies are needed. But the effect size is remarkable, especially considering that nicotine patch is an established, FDA-approved treatment. No serious adverse events were attributed to psilocybin in the study. The participants were psychiatrically healthy adults, carefully screened, and the psilocybin was administered in a controlled clinical setting.

The Exercise Connection

If psilocybin works for addiction, could it work even better when combined with other interventions? Fabiano and colleagues (2026) published a commentary exploring the potential synergy between psychedelics and exercise for treating major depressive disorder. Their argument is built on overlapping biological mechanisms that, in theory, could amplify each other’s effects.

The key mechanisms they identify include:

• BDNF signaling: Psychedelics acutely enhance brain-derived neurotrophic factor (BDNF) signaling by binding directly to TrkB receptors, while exercise provides sustained BDNF elevation through repeated sessions. Together, they could create both rapid and lasting neuroplastic changes.
• Complementary brain regions: Psychedelics primarily affect cortical regions with high serotonin 2A receptor density but show modest effects in the hippocampus. Exercise, on the other hand, boosts hippocampal neurogenesis, increases hippocampal volume, and improves memory. Combined, they could produce broader neuroplasticity across the brain.
• Default mode network effects: Psychedelics temporarily disrupt connectivity between the hippocampus and the default mode network (the brain network associated with rumination and self-referential thinking). Exercise can then normalize and sustain these connectivity changes, potentially extending the antidepressant benefits.
• Behavioral changes: Multiple studies show that psychedelic use is associated with increased physical activity afterward. People who undergo psilocybin therapy frequently report improvements in diet, exercise habits, and overall health behaviors. Psychedelics may increase openness to new experiences, making it easier to adopt and maintain exercise routines.

Why Exercise Matters for Stress Biology

The exercise piece of this story has its own independent evidence base. Caplin and colleagues (2021) demonstrated that a single 30-minute bout of vigorous exercise significantly dampened the cortisol response to a subsequent psychosocial stressor. The effect was dose-dependent: more intense exercise produced greater stress buffering.

Specifically, participants who exercised at 70% of their heart rate reserve showed lower total cortisol levels, reduced cortisol reactivity, and faster recovery to baseline compared to those who exercised at lower intensities. The mechanism appears to involve a negative feedback loop: the cortisol released during intense exercise suppresses the cortisol response to later stressors.

This is relevant to psychedelic therapy because one of the challenges of high-dose psychedelic experiences is managing the intense emotional material that surfaces. If exercise can build resilience to acute stress, it could help people engage more deeply with their psychedelic experience rather than becoming overwhelmed by it.

What This Means (and What It Doesn’t)

It’s important to be clear about what this research does and does not support. Psilocybin is not currently legal for clinical use in most jurisdictions. These studies were conducted in controlled settings with careful screening, professional supervision, and standardized psychotherapy. The results do not endorse recreational use or self-medication.

What the research does support is a fundamental rethinking of how we approach treatment-resistant conditions. When 50% of people with major depression don’t respond to first-line treatments, and when the most widely used smoking cessation aids fail more often than they succeed, alternative approaches deserve rigorous investigation.

The combination of psychedelics with exercise is still theoretical. No clinical trial has tested this combination directly. But the overlapping mechanisms are compelling enough that Fabiano and colleagues argue future research is warranted.

The Practical Takeaway

Even without access to psychedelic therapy, the exercise findings are immediately actionable. Vigorous exercise, even a single session, can measurably reduce your physiological stress response. If you’re dealing with depression, anxiety, or addiction, exercise isn’t a substitute for professional treatment, but it’s a powerful complement to it. The research consistently shows effects comparable to medication and therapy.

Explore Your Options

Understanding where you stand with mental health is the first step toward meaningful change. Explore our self-discovery tools to assess your personality, attachment patterns, and wellness baseline. If you’re struggling with addiction, depression, or treatment-resistant symptoms, consider scheduling a session to discuss evidence-based options with a clinician who stays current with the research.